台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    100.5
  • 漲跌
    ▼3.0
  • 漲幅
    -2.90%
  • 成交量
    1,644
  • 產業
    上櫃 生技醫療類股
  • 309人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智擎 (4162)籌碼相關-凱基-豐中 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw03/0803/1803/2804/2005/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0202/1202/249095100105110115120125May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

凱基-豐中 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/2500.0012104.58104.50-121,719-0.70%
2025/03/2100.000106.00106.5001,7140.00%
2025/03/200106.1700.00106.0001,7130.00%
2025/03/146105.5000.00105.0061,7130.35%
2025/03/1000.001105.50107.00-11,686-0.06%
2025/03/0712108.0800.00107.50121,6650.72%
2025/03/051114.501115.50115.5001,6450.00%
2025/03/044113.0000.00114.5041,6340.24%
2025/03/035112.5000.00112.5051,6200.31%
2025/02/2615116.171118.00115.50141,5530.90%
2025/02/201110.0000.00110.0011,3890.07%
2025/02/180111.5000.00110.0001,4010.00%
2025/02/1700.001113.00112.50-11,397-0.07%
2025/02/1300.001111.50111.50-11,413-0.07%
2025/02/121111.0000.00112.0011,4080.07%
2025/02/111111.0000.00109.0011,3920.07%
2025/02/101119.0000.00118.5011,3370.07%
2025/02/072118.752119.00120.5001,3510.00%
2025/02/062119.002119.25119.0001,3290.00%
2025/01/0900.00299.8094.60-21,341-0.15%
2025/01/0600.002101.00101.50-21,259-0.16%
2024/12/18388.3000.0088.8031,2200.25%
2024/12/1200.00190.1090.20-11,199-0.08%
2024/11/151100.0000.0099.9019890.10%
2024/11/1200.006102.00104.00-6916-0.65%
2024/11/111104.0000.00103.5018820.11%
2024/11/0700.001106.00103.50-1852-0.12%
2024/11/0500.001106.00106.00-1782-0.13%
2024/11/043101.173104.00100.0007580.00%
2024/11/016106.251105.00105.0057300.68%
2024/10/284101.382100.00102.0025760.35%
2024/10/2500.00298.4097.40-2513-0.39%
2024/10/2400.00198.9098.30-1494-0.20%
2024/10/23194.5000.0093.7014240.24%
2024/10/0800.00193.2091.10-1507-0.20%
2024/09/2400.00788.9090.20-7612-1.14%
2024/09/2000.00188.0087.40-1644-0.16%
2024/09/19284.20286.1086.0006360.00%
2024/08/28186.7000.0086.6017290.14%
2024/08/21187.1000.0086.6017460.13%
2024/08/2000.00485.5085.80-4742-0.54%
2024/08/1900.00584.4684.50-5739-0.68%
2024/08/13384.8300.0084.4037720.39%
2024/08/12684.5300.0084.9067800.77%
2024/08/07286.7000.0086.7027940.25%
2024/08/05183.20284.3083.00-1764-0.13%
2024/08/01194.9000.0094.5017360.14%
2024/07/1900.00194.9094.20-1708-0.14%
2024/07/1500.00199.4098.40-1663-0.15%
2024/07/1100.00195.8095.20-1650-0.15%
2024/07/09197.10597.2096.30-4668-0.60%
2024/07/0800.001100.50100.50-1655-0.15%
2024/07/05196.8000.0097.5016250.16%
2024/07/01299.80599.14101.00-3610-0.49%
2024/06/26297.70297.7097.6005760.00%
2024/06/2500.00492.9394.30-4568-0.70%
2024/06/20194.6000.0094.5016350.16%
2024/06/19394.6000.0093.8036370.47%
2024/06/1300.00296.6096.90-2651-0.31%
2024/06/0700.00492.6094.50-4644-0.62%
2024/05/2800.00292.5092.30-2760-0.26%
2024/05/27291.551291.6791.70-10776-1.29%
2024/05/1700.000.297.1097.90-0.2872-0.02%
2024/05/14195.1000.0094.3011,0430.10%
2024/05/0800.00193.1094.00-11,096-0.09%
2024/05/0300.00194.0093.80-11,364-0.07%
2024/04/290.295.20193.1095.30-0.81,430-0.06%
2024/04/2300.00189.1090.20-11,498-0.07%
2024/04/22189.4000.0088.0011,5120.07%
2024/04/1700.00293.0092.60-21,541-0.13%
2024/04/10198.80199.5098.8001,6420.00%
2024/04/0200.00299.4598.90-21,780-0.11%
2024/04/0100.003100.0099.60-31,805-0.17%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-26天前
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章